Science
Mechanism of Action
Operates through a triple-pathway approach: it inhibits tyrosinase activity to curtail melanin synthesis, blocks the migration of melanosomes to keratinocytes, and uniquely triggers cellular autophagy to degrade existing pigment. Concurrently, it downregulates pro-inflammatory cytokines like TNF-α and IL-1β to maintain a calm skin environment.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Standardized extract trials demonstrate visible skin lightening within 7 days via autophagy-mediated melanin degradation.
- 02 In vitro B16/F10 melanoma cell assays confirm dose-dependent inhibition of melanin content and tyrosinase enzymatic activity.
- 03 Research into active Atractylenolide I components reveals significant reduction in inflammatory markers and high biological compatibility.
Transparency
Dusting Analysis
While visible results are recorded at concentrations as low as 0.1%, many mass-market formulations include it at trace amounts (<0.01%) purely for label marketing. For physiological impact on melanin degradation, a minimum of 0.1% is required.
The Formula
Formulation
Stability
The extract is highly stable against oxidation in neutral formulations but shows significant degradation and loss of efficacy in acidic environments where pH drops below 5.0.
Synergies
- Niacinamide
- Alpha-Arbutin
- Licorice Root Extract
- Tranexamic Acid
Conflicts
- L-Ascorbic Acid (low pH)
- Glycolic Acid
- Strong Oxidizing Agents
Safety
Safety Profile
Classified as GRAS (Generally Recognized as Safe) for oral intake; topical application is considered non-sensitizing and safe for long-term use in brightening regimens.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional multi-pathway brightening agent that offers rapid results and high skin tolerance, provided it is formulated within its stable pH range.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources